Medibio Limited announced it has commenced the initial phase of testing of its consumer mental health app (Consumer App). The company's pioneering work in the use of biometric data to aid in the early detection and screening of mental health conditions, together with its patented method of assessing stress by monitoring overnight heart rate 1, underpins the functionality of the Consumer App, which includes both biometric and psychometric assessments. The Consumer App's unique biometric functionality matches day and night heart rate activity and its variability throughout the night (drawn from wearable devices such as Garmin or the Apple Watch) against sleep architecture parameters and physical activity levels, producing an overall daily score to help users objectively measure, monitor, and manage stress levels and improve them over time. This unique feature will set it apart from competitors in the marketplace. Market research indicates no other viable in- store mental health app has patent protected biometric functionality. The Consumer App will also support users whom do not have a wearable device, through Its interactive psychometric assessment feature, which utilizes a clinically validated questionnaire to indicate stress levels. In 2018 (pre-COVID) the estimated market size of global mHealth apps (using smartphones to keep track of well-being) was USD 12.4 billion and projected to expand at a compound annual growth rate of 44.7% through 2026. The COVID-19 pandemic and its many social and economic consequences has exacerbated mental health conditions among the global population. In the United States, the increased stress and worry has adversely impacted the mental health of an estimated 53% of adults 3. Medibio intends to address this increased need and demand for mobile mental health services through the development and launch of its Consumer App, which the Company plans to make available on Android and IOS platforms, with an expected commercial launch in advance of Mental Health Awareness Week in the United States in October 2021.